# Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression

> **NCT00429169** · PHASE4 · TERMINATED · sponsor: **New York State Psychiatric Institute** · enrollment: 101 (actual)

## Conditions studied

- Depression

## Interventions

- **DRUG:** Paroxetine
- **DRUG:** Bupropion

## Key facts

- **NCT ID:** NCT00429169
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-06
- **Primary completion:** 2010-01
- **Final completion:** 2013-01
- **Target enrollment:** 101 (ACTUAL)
- **Why stopped:** Interim analysis showed differential treatment effects.
- **Last updated:** 2018-10-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00429169

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00429169, "Paroxetine/Bupropion in Suicide Attempters/Ideators With Major Depression". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00429169. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*